Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Kamada Ltd.

Market Cap 1.25B 430M 371M 342M 320M 600M 40.86B 610M 4.04B 1.58B 19.89B 1.61B 1.58B 68.87B P/E Ratio 2026 *
-
P/E Ratio 2027 * -
Enterprise Value 1.25B 430M 371M 342M 320M 600M 40.86B 610M 4.04B 1.58B 19.89B 1.61B 1.58B 68.87B EV / Sales 2026 *
2.15x
EV / Sales 2027 * 1.95x
Free-Float
54.51%
Yield 2026 *
-
Yield 2027 * -
Manager TitleAgeSince
Chief Executive Officer 57 2015-06-30
Director of Finance/CFO 55 2017-12-30
Chief Operating Officer 53 2016-10-31
Director TitleAgeSince
Director/Board Member 75 1990-12-12
Chairman 77 2013-03-06
Chairman 55 2020-08-11
Change 5-day change 1-year change 3-year change Capi.($)
-0.53%-1.28% - - 430M
+0.11%-3.67%+17.30%-18.82% 62.28B
+1.44%+5.33%+68.08%+223.49% 60.59B
+0.70%+29.50%+29.50%+29.50% 39.55B
+0.26%+9.80%-55.40%-64.79% 36.8B
+0.05%+2.41%+51.20%-36.17% 29.53B
+0.65%+6.01%+56.79%+74.77% 21.68B
+0.54%+5.21%+82.49%-59.59% 19.8B
+4.80%-0.20%-5.33%+112.95% 16.96B
+0.18%-1.66%+49.80%+101.47% 16.16B
Average +0.82%+3.10%+32.71%+40.31% 33.71B
Weighted average by Cap. +0.80%+2.99%+31.06%+46.41%

Financials

2026 *2027 *
Net sales 585M 200M 173M 159M 149M 280M 19.04B 284M 1.88B 734M 9.27B 752M 736M 32.1B 642M 220M 190M 175M 164M 307M 20.91B 312M 2.07B 806M 10.18B 825M 808M 35.23B
Net income 72.01M 24.68M 21.31M 19.64M 18.38M 34.45M 2.35B 34.98M 232M 90.41M 1.14B 92.61M 90.63M 3.95B 104M 35.51M 30.67M 28.26M 26.46M 49.58M 3.38B 50.35M 334M 130M 1.64B 133M 130M 5.69B
Net Debt - -
Logo Kamada Ltd.
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.
Employees
-
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!